Multiple Causes of Cardiotoxic Effects in Patients With Chronic Myeloid Leukemia-Reply

enthalten in: JAMA oncology | 2016

von Douxfils, J. | Haguet, H. | Dogné, J.

Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival : A Systematic Review and Meta-analysis

enthalten in: JAMA oncology | 2016

von Douxfils, J. | Haguet, H. | Mullier, F. | +3